InvestSMART

Imricor Medical Systems Inc (ASX: IMR) - Announcements

Current share price for IMR : $1.960 0.04 (2.08%)+

ASX company news and announcements for Imricor Medical Systems Inc (IMR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Imricor Medical Systems Inc (IMR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Imricor Medical Systems Inc (IMR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Imricor Medical Systems Inc (IMR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$703 Voluntary Suspension 23 Oct 2023 9:22AM $0.450 $1.960 risen by 335.56%
$703 Trading Halt 19 Oct 2023 9:01AM $0.450 $1.960 risen by 335.56%
$703 Imricor Commences New Activation of Site in Croatia 12 Oct 2023 10:25AM $0.545 $1.960 risen by 259.63%
$703 Notification of cessation of securities - IMR 10 Oct 2023 9:36AM $0.560 $1.960 risen by 250%
$703 Cleansing Notice 2 Oct 2023 9:47AM $0.505 $1.960 risen by 288.12%
$703 Application for quotation of securities - IMR 2 Oct 2023 9:44AM $0.505 $1.960 risen by 288.12%
$703 Proposed issue of securities - IMR 29 Sep 2023 9:29AM $0.560 $1.960 risen by 250%
$703 Funding Facility Drawdown 29 Sep 2023 9:25AM $0.560 $1.960 risen by 250%
$703 Change of Registered Address in Australia 28 Sep 2023 11:14AM $0.570 $1.960 risen by 243.86%
$703 Approval to Commence VISABL-VT Trial in Germany 26 Sep 2023 9:46AM $0.630 $1.960 risen by 211.11%
$703 Business Update 20 Sep 2023 9:16AM $0.570 $1.960 risen by 243.86%
$703 Release from Voluntary Escrow 8 Sep 2023 9:44AM $0.610 $1.960 risen by 221.31%
$703 Imricor Receives US$1.158 Million Grant 6 Sep 2023 9:45AM $0.600 $1.960 risen by 226.67%
$703 Becoming a substantial holder 29 Aug 2023 10:11AM $0.560 $1.960 risen by 250%
$703 H1 FY23 Results Investor Presentation 24 Aug 2023 8:55AM $0.680 $1.960 risen by 188.24%
$703 Imricor releases Half Year Results for 1H 2023 24 Aug 2023 8:52AM $0.680 $1.960 risen by 188.24%
$703 Appendix 4D and Half Year Report & Accounts 24 Aug 2023 8:51AM $0.680 $1.960 risen by 188.24%
$703 Notification regarding unquoted securities - IMR 18 Aug 2023 10:17AM $0.815 $1.960 risen by 140.49%
$703 Cleansing Notice 18 Aug 2023 9:49AM $0.790 $1.960 risen by 148.10%
$703 Application for quotation of securities - IMR 17 Aug 2023 11:42AM $0.800 $1.960 risen by 145%
$703 Proposed issue of securities - IMR 16 Aug 2023 10:38AM $0.690 $1.960 risen by 184.06%
$703 Imricor Raises A$2.84 million via Placement 16 Aug 2023 9:57AM $0.660 $1.960 risen by 196.97%
$703 Details of 1H23 Results Investor Webinar 15 Aug 2023 11:29AM $0.630 $1.960 risen by 211.11%
$703 Imricor Receives Ethics Approval to Commence VISABL-VT Trial 1 Aug 2023 8:52AM $0.480 $1.960 risen by 308.33%
$703 Imricor Q2 FY23 Quarterley Activities Report and Appendix 4C 27 Jul 2023 10:01AM $0.440 $1.960 risen by 345.45%

251 - 275 of 600 results

Page 11 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.